A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAP / capreomycin

[Related PubMed/MEDLINE]
Total Number of Papers: 31
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAP  (>> Co-occurring Abbreviation)
Long Form:   capreomycin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Application of machine learning techniques to tuberculosis drug resistance analysis. AK, AUC, CIP, GBT, LR, MOX, Mtb, OFX, PZA
2018 Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan. AMK, DST, EMB, KM, KPK, MDR, MOX, Mtb, OFX, PZA, RIF, SM, TB, XDR
2018 Pyrosequencing: a rapid and effective sequencing method to diagnose drug-resistant tuberculosis. FQs, KAN, Mtb, PSQ, RIF, SLIs
2016 Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains. AMK, FQ, KAN, MDR, XDR-TB
2016 Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014. AM, DST, EA, EMB, GAT, KM, LVX, MDR-TB, MOX, OFX, PAS, PZA, RIF, SM
2015 Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report. AMK, CIP, CYC, ETH, KAN, NTM, OFX, PAS, XDR-TB
2015 Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance. AMK, FLQ, KAN, RIF
2015 Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis. ---
2015 Evaluation of direct microplate nitrate reductase assay as a rapid method for the detection of multiple and extensively tuberculosis drug resistance. AMK, KAN, OFX, RIF
10  2015 Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. AMK, FQ, INH, KAN, MGIT, PSQ, RIF, TB
11  2015 In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates. AMK, CLO, EMB, FICIs, LEV, MDR-TB, MIC, MOX, XDR
12  2015 Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. AMK, KAN, LPA, MODS, MOX, OFX, PSQ, RIF
13  2015 Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis. AFIP, AMK, ETH, MDR-TB, Mtb, OFL
14  2014 Characterization of a novel mutation in the overlap of tlyA and ppnK involved in capreomycin resistance in Mycobacterium. ---
15  2014 Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru. KAN, MDR-TB, MTBC, XDR-TB
16  2014 Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China. AMK, KAN, MDR-TB, MICs, TB
17  2014 Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand. AK, KM, MDR-TB, XDR-TB
18  2014 Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. KAN, MDR-TB, OFX, RIF
19  2014 Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. AMK, DST, KAN, MOX, OFX, RIF, SNPs
20  2014 Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China. AMK, DSTs, LEV, MDR, pre-XDR, XDR
21  2014 Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. AKM, EMB, KAN, katG315, OFX, PZA, RIF, SM
22  2014 [Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains]. AMK, CFX, GFX, KAN, MDR, MFX, MIC, OFX
23  2013 A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border. AMK, CLF, CLS, ETH, KAN, MDR, Mtb, OFL
24  2013 Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. AMK, EMB, INH, KM, PZA, RIF
25  2013 Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region. AMK, DST, ETA, MDR-TB, Mtb, OFX, RIF, XDR-TB
26  2013 Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. AMK, KAN, MIC, SLDs, UTR
27  2012 Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. AMK, KAN, Mtb
28  2012 Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. AMK, INH, KAN, MIRU-VNTR, OFX, RIF
29  2012 Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. AMK, CCs, KAN, MICs
30  2011 Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. AMK, CIP, EMB, KAN, OFX, PZA, RIF
31  2010 Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar. CFM, ETH, KM, MDR, OFX, PAS, RBU